Review of the Landmark VARSITY Trial.
作者信息
Feagan Brian
机构信息
Western University Alimentiv Inc London, Ontario, Canada.
出版信息
Gastroenterol Hepatol (N Y). 2021 Jul;17(7):330-332.
Abstract
摘要
相似文献
1
Review of the Landmark VARSITY Trial.
Gastroenterol Hepatol (N Y). 2021 Jul;17(7):330-332.
2
Dietary supplement use by varsity athletes at a Canadian university.
Int J Sport Nutr Exerc Metab. 2005 Apr;15(2):195-210. doi: 10.1123/ijsnem.15.2.195.
3
Sweat Loss and Hydration Habits of Female Olympic, Varsity and Recreational Ice Hockey Players.
Int J Sports Med. 2019 May;40(6):416-422. doi: 10.1055/a-0877-7028. Epub 2019 Apr 23.
4
Implementation of Injury and Illness Surveillance Protocols in Varsity Athletes.
Clin J Sport Med. 2020 Jul;30(4):321-334. doi: 10.1097/JSM.0000000000000587.
5
Smartphones and Varsity Athletes: A Complicated Relationship.
Front Sports Act Living. 2021 Jan 6;2:560031. doi: 10.3389/fspor.2020.560031. eCollection 2020.
6
Misuse of prescription stimulant medication in a sample of college students: examining differences between varsity athletes and non-athletes.
Addict Behav. 2015 Dec;51:44-50. doi: 10.1016/j.addbeh.2015.07.004. Epub 2015 Jul 17.
7
Nutrition knowledge of female varsity athletes and university students.
J Am Diet Assoc. 1987 Dec;87(12):1660-4.
8
Exploring simulated driving performance among varsity male soccer players.
Traffic Inj Prev. 2019;20(5):528-533. doi: 10.1080/15389588.2019.1601715. Epub 2019 Jun 5.
9
Comparative studies of color fields, visual acuity fields, and movement perception limits among varsity athletes and non-varsity groups.
Percept Mot Skills. 1983 Jun;56(3):887-92. doi: 10.2466/pms.1983.56.3.887.
10
Varsity athletes have lower 2D:4D ratios than other university students.
J Sports Sci. 2012;30(2):135-8. doi: 10.1080/02640414.2011.630744. Epub 2011 Dec 1.
本文引用的文献
1
Long-term safety of vedolizumab for inflammatory bowel disease.
Aliment Pharmacol Ther. 2020 Oct;52(8):1353-1365. doi: 10.1111/apt.16060. Epub 2020 Sep 2.
2
Vedolizumab versus Adalimumab for Moderate-to-Severe Ulcerative Colitis.
N Engl J Med. 2019 Sep 26;381(13):1215-1226. doi: 10.1056/NEJMoa1905725.
3
Sustained Clinical Remission With Vedolizumab in Patients With Moderate-to-Severe Ulcerative Colitis.
Inflamm Bowel Dis. 2019 May 4;25(6):1028-1035. doi: 10.1093/ibd/izy323.
4
Safety and Positioning of Vedolizumab in Patients With Inflammatory Bowel Disease.
Gastroenterol Hepatol (N Y). 2018 Apr;14(4):244-246.
5
Evolution of the Randomized Controlled Trial in Inflammatory Bowel Disease: Current Challenges and Future Solutions.
Inflamm Bowel Dis. 2018 Sep 15;24(10):2155-2164. doi: 10.1093/ibd/izy117.
Zotero 插件